<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tong S</submitter><funding>Chapman University</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>1701</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8807785</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Interferon-gamma (IFN-γ) is shown to stimulate melanoma development and progression. However, the underlying mechanism has not been completely defined. Our study aimed to determine the role of neuronal nitric oxide synthase (nNOS)-mediated signaling in IFN-γ-stimulated melanoma progression and the anti-melanoma effects of novel nNOS inhibitors. Our study shows that IFN-γ markedly induced the expression levels of nNOS in melanoma cells associated with increased intracellular nitric oxide (NO) levels. Co-treatment with novel nNOS inhibitors effectively alleviated IFN-γ-activated STAT1/3. Further, reverse phase protein array (RPPA) analysis demonstrated that IFN-γ induced the expression of HIF1α, c-Myc, and programmed death-ligand 1 (PD-L1), in contrast to IFN-α. Blocking the nNOS-mediated si</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).</pubmed_title><pmcid>PMC8807785</pmcid><funding_grant_id>R01 GM049725</funding_grant_id><funding_grant_id>Faculty Opportunity Grant</funding_grant_id><funding_grant_id>R35 GM131788</funding_grant_id><funding_grant_id>K08CA179084</funding_grant_id><funding_grant_id>K08 CA179084</funding_grant_id><funding_grant_id>1R35GM131788-01</funding_grant_id><pubmed_authors>Silverman RB</pubmed_authors><pubmed_authors>Tong S</pubmed_authors><pubmed_authors>Patel A</pubmed_authors><pubmed_authors>Cinelli MA</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>El-Sayed NS</pubmed_authors><pubmed_authors>Yang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).</name><description>Interferon-gamma (IFN-γ) is shown to stimulate melanoma development and progression. However, the underlying mechanism has not been completely defined. Our study aimed to determine the role of neuronal nitric oxide synthase (nNOS)-mediated signaling in IFN-γ-stimulated melanoma progression and the anti-melanoma effects of novel nNOS inhibitors. Our study shows that IFN-γ markedly induced the expression levels of nNOS in melanoma cells associated with increased intracellular nitric oxide (NO) levels. Co-treatment with novel nNOS inhibitors effectively alleviated IFN-γ-activated STAT1/3. Further, reverse phase protein array (RPPA) analysis demonstrated that IFN-γ induced the expression of HIF1α, c-Myc, and programmed death-ligand 1 (PD-L1), in contrast to IFN-α. Blocking the nNOS-mediated si</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-05T13:57:53.367Z</modification><creation>2025-04-05T13:57:53.367Z</creation></dates><accession>S-EPMC8807785</accession><cross_references><pubmed>35105915</pubmed><doi>10.1038/s41598-022-05394-6</doi></cross_references></HashMap>